Lv5
1130 积分 2022-10-24 加入
CONSORT 2025 statement: updated guideline for reporting randomised trials
16天前
已完结
[Chinese expert consensus on screening and management of fecal microbiota transplantation donors (2022 edition)]
24天前
已完结
The next generation of evidence-based medicine
1个月前
已完结
Central precocious puberty: a review of diagnosis, treatment, and outcomes
1个月前
已完结
[Expert consensus on the diagnosis and treatment of central precocious puberty(2022)]
1个月前
已完结
[Chinese guideline for diagnosis and treatment of allergic rhinitis (2022, revision)]
1个月前
已完结
[Guideline for diagnosis and treatment of pediatric allergic rhinitis (2022, revision)]
1个月前
已完结
儿童体格发育评估与管理临床实践专家共识
2个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
2个月前
已完结
[Expert consensus on immunotherapy for small cell lung cancer (2025 edition)]
3个月前
已完结
皖公网安备34019202002308
